A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.
Saved in:
| Title: | A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. |
|---|---|
| Authors: | Spearman P (AUTHOR), Lally MA (AUTHOR), Elizaga M (AUTHOR), Montefiori D (AUTHOR), Tomaras GD (AUTHOR), McElrath MJ (AUTHOR), Hural J (AUTHOR), De Rosa SC (AUTHOR), Sato A (AUTHOR), Huang Y (AUTHOR), Frey SE (AUTHOR), Sato P (AUTHOR), Donnelly J (AUTHOR), Barnett S (AUTHOR), Corey LJ (AUTHOR), HIV Vaccine Trials Network of NIAID (CORPORATE AUTHOR), Spearman, Paul1 (AUTHOR), Lally, Michelle A (AUTHOR), Elizaga, Marnie (AUTHOR), Montefiori, David (AUTHOR) |
| Source: | Journal of Infectious Diseases. 2011, Vol. 203 Issue 8, p1165-1173. 9p. |
| Database: | Environment Complete |
| ISSN: | 00221899 |
|---|---|
| DOI: | 10.1093/infdis/jiq175 |
